The Power List 2019

Jim Agalloco

President, Agalloco & Associates

Madhavan (Madhu) Balachandran

Business Owner, MJB Consultants

Hal Baseman

Chief Operating Officer, Valsource

John E. Bournas

President and Chief Executive Officer, International Society for Pharmaceutical Engineering (ISPE)

Jim Breen

Jim Breen

Jon Coffman

Global Head Innovation and Technology, Boehringer Ingelheim

Gary Cunnington

Global Head of Business Consultancy (CTSU), Boehringer Ingelheim

Carlo De Notaristefani

Executive Vice President, Global Operations, Teva Pharmaceuticals

Doug Hausner

Associate Director, C-SOPS/Department of Chemical and Biochemical Engineering, Rutgers University

Maik Jornitz

Chief Executive Officer, G-CON Manufacturing

Tony Hitchcock

Technical Director, Cobra Biologics

Richard Johnson

President and Chief Executive Officer, Parenteral Drug Association

Johannes Khinast

Head of the Institute for Process and Particle Engineering, the Graz University of Technology; Scientific Director, Research Center Pharmaceutical Engineering GMBH

Jim Miller

Content Advisor and Consultant to the Drug, Chemical & Associated Technologies Association (DCAT)

Michael O’Brien

President, NextGenTech

Rino Rappuoli

Chief Scientist and Head External R&D, GSK

Guido Rasi

Executive Director, European Medicines Agency

Andrew D. Skibo

Technical Advisor to EVP Operations and IT; Astrazeneca

Gil Roth

Founder and President, Pharma & Biopharma Outsourcing Association

Deepak Sapra

Senior Vice President & Head of Pharamceutical Service and Active Ingredients, DR Reddy's Laboratories

Moncef Slaoui

Partner and Member of Scientific Advisory Board, Medicxi

Cornell Stamoran

VP of Corporate Strategy and Government Affairs, Catalent Pharma Solutions

James N. Thomas

Chief Executive Officer and Founding Partner, Just Biotherapeutics

Bernhardt Trout

Raymond F. Baddour, SCD, (1949) Professor of Chemical Engineering, Massachusetts Institute of Technology

Michael Vandiver

Vice President of Manufacturing & Plant Design, Just Biotherapeutics

Stéphane Bancel

Chief Executive Officer, Moderna Therapeutics

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

Olivier Brandicourt

Chief Executive Officer, Sanofi

Minzhang Chen

Chief Executive Officer, WuXi STA

John Chiminski

President and Chief Executive Officer, Catalent

Stanley Crooke

Chairman and Chief Executive Officer, Ionis Pharmaceuticals

Kenneth C. Frazier

Chairman and Chief Executive Officer, Merck Sharp & Dohme.

Belén Garijo

Chief Executive Officer, Healthcare, Merck

Erik Gatenholm

Co-Founder and Chief Executive Officer, CELLINK

Jeff Jonas

Chief Executive Officer, Sage Therapeutics

Steven M. Klosk

President and Chief Executive Officer, Cambrex

Rachel Haurwitz

President and Chief Executive Officer, Caribou Biosciences

Sandy Macrae

President and Chief Executive Officer, Sangamo Therapeutics

Ankit Mahadevia

Kiran Mazumdar-Shaw

Chairperson and Managing Director, Biocon

Ravi Nalliah

Chief Executive Officer, TrakCel

Vasant Narasimhan

Chief Executive Officer, Novartis

Rodger Novak

Co-Founder and President, CRISPR Therapeutics

Jessica Richman

Co-Founder and Chief Executive Officer, Ubiome

Leonard Schleifer

Founder and Chief Executive Officer, Regeneron Pharmaceuticals

Severin Schwan

Chief Executive Officer, Roche Group

Raman Singh

Chief Executive Officer, Mundipharma, Singapore

Martin Tolar

President and Chief Executive Officer, Alzheon

Emma Walmsley

Chief Executive Officer, GlaxoSmithKline

Claudia Zylberberg

Co-founder, Chief Executive Officer and President, Akron Biotechnology

Phil S. Baran

Darlene Shiley Chair in Chemistry, Scripps Research Institute

Lisa Brannon-Peppas

Owner and Chief Executive Officer, PeppChem Consulting

Paolo Colombo

Emeritus Professor, Università degli Studi di Parma

Charles Cooney

Robert T. Haslam (1911) Professor of Chemical and Biochemical Engineering, Emeritus, Massachusetts Institute of Technology

Lloyd Czaplewski

Director, Chemical Biology Ventures

Chi Van Dang

Scientific Director, Ludwig Institute for Cancer Research; Professor, Wistar Institute

Meindert Danhof

Retired

Michele De Luca

Director, Centre for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia

Kenneth Getz

Director of Sponsored Programs and Associate Professor, Tufts University School of Medicine; Founder and Chairman, CISCRP

Michael Jensen

Director, Ben Towne Center for Childhood Cancer, Seattle Children’s Research Institute

Carl H. June

Richard W. Vague Professor in Immunotherapy, University of Pennsylvania

Robert Samuel Langer

David H. Koch Institute Professor, Massachusetts Institute of Technology

Bruce Levine

President-Elect 2018-2020, International Society for Cell and Gene Therapy

Roderick MacKinnon

Co-Founder and Chair, Flex Pharma

Joan Mannick

Co-Founder, Chief Medical Officer and Member of the Board of Directors, resTORbio

Chris Mason

Founder and Chief Scientific Officer, AvroBIo; Professor of Cell and Gene Therapy, Advanced Centre for Biochemical Engineering, University College London

Graziella Pellegrini

Director, Cell Therapy Programme, Centre for Regenerative Medicine “Stefano Ferrari,” University of Modena and Reggio Emilia

Nicholas A. Peppas

Cockrell Family Regents Chair in Engineering #6; Professor of Chemical Engineering, the University of Texas at Austin

Christopher J.H. Porter

Director, Monash Institute of Pharmaceutical Sciences, Monash University

Dolores Schendel

Chief Executive Officer and Chief Scientific Officer, Medigene

Peter Seeberger

Managing Director, Max-Planck Institute Colloids and Interfaces

John Talley

Chief Scientific Officer, Euclises Pharmaceuticals

Harold Varmus

Lewis Thomas University Professor, Weill Cornell Medical College

Adrian Wildfire

Scientific Director, SGS

Shinya Yamanaka

Director and Professor Center for iPS Cell Research and Application (CiRA), Kyoto University

Steve Arlington

President, Pistoia Alliance

John Arnold

Founder and Co-Chair, Laura and John Arnold Foundation

Michael A. Arnold

Senior Director, Investigational Products Business Process Owner, Pfizer

Peter B. Bach

Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center

Dario Campana

Scientific Founder, Unum Therapeutics, Nkarta and Medisix Therapeutics; Professor, Department of Pediatrics, National University of Singapore

Thomas Cech

Distinguished Professor, University of Colorado Boulder

Steve Davis

Chief Executive Officer, PATH

Sue Desmond-Hellmann

Chief Executive Officer, BIll & Melinda Gates Foundation

Massimo Dominici

Associate Professor, Medical Oncology, University Hospital of Modena and Reggio Emilia

Julie Gerberding

Executive Vice President & Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health, Merck Sharp & Dohme

Dalvir Gill

Chief Executive Officer, TransCelerate Biopharma

Ben Goldacre

Senior Clinical Research Fellow, Nuffield Department of Primary Care Health Sciences, University of Oxford; Co-Founder, AllTrials

Margaret Hamburg

Chair of the Board, American Association for the Advancement of Science

John Hammergren

Retired. Former Chairman and Chief Executive Officer, McKesson Corporation

Jackie Hunter

Chief Executive Officer, BenevolentBio; Board Director of BenovolentAI

Amir Kalali

Chief Curator and Chairman, CNS Summit

Subhash Kapre

Chief Executive Officer, Inventprise LLC

Faith Osier

Principal Investigator, Kemri-Wellcome Trust Research Program; Professor of Malaria Immunology, University of Oxford

Mike Rea

Chief Executive Officer, IDEA Pharma

Melinda Richter

Global Head of JLABS, Johnson & Johnson Innovation

Ros Smyth

Director, UCL Great Ormond Street Institute of Child Health

Abbe Steel

Chief Executive Officer, HealthiVibe, LLC

Matthew H. Todd

Chair of Drug Discovery, University College London

Martin VanTrieste

President and Chief Executive Officer, Civica Rx

J. Craig Venter

Founder, chairman and Chief Executive Officer, J. Craig Venter Institute